Hematology NewsALC/AMC prognostic in mantle cell lymphomaMay 19, 2017Mantle Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsIn mantle cell lymphoma, triple therapy proves too toxicApril 24, 2017Mantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsNewly diagnosed mantle cell lymphoma is ‘one of the hardest consultations’April 21, 2017Mantle Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsMAGNIFY in relapsed/refractory mantle cell lymphomaApril 7, 2017Mantle Cell LymphomaFollicular Lymphoma
Oncology PracticeUnavoidable, random DNA replication errors are the most common cancer driversMarch 23, 2017Breast CancerPediatricsPatient & Survivor CareGenitourinary CancerHodgkin LymphomaMantle Cell Lymphoma
Hematology NewsPhase III trial: VZV protects auto-HCT patientsFebruary 25, 2017Multiple MyelomaT Cell LymphomasMantle Cell LymphomaIndolent LymphomaAggressive LymphomasPreventive CareLymphoma & Plasma Cell Disorders
Hematology NewsFor mantle cell lymphoma, VR-CAP beat R-CHOPFebruary 24, 2017Mantle Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsIbrutinib, palbociclib yield durable complete responses in pretreated mantle cell lymphomaFebruary 8, 2017Mantle Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsBortezomib-based regimen led to durable remissions in mantle cell lymphomaFebruary 5, 2017Mantle Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsRituximab after ASCT boosted survival in mantle cell lymphomaJanuary 21, 2017Mantle Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsVIDEO: First multicenter trial of CAR T cells shows response in DLBCLJanuary 19, 2017Mantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell Disorders
Hematology NewsChemo-free induction regimen shines in MCLJanuary 18, 2017Mantle Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsRituximab vanquished MRD in mantle cell lymphomaJanuary 17, 2017Mantle Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsVIDEO: Obinutuzumab bests rituximab for PFS in follicular lymphomaDecember 6, 2016Indolent LymphomaLymphoma & Plasma Cell DisordersMantle Cell LymphomaFollicular Lymphoma
